Human Amniotic Epithelial Stem Cells
DFSC-2019（CR）-001
Phase 1 mab completed
Quick answer
Human Amniotic Epithelial Stem Cells for Parkinson's Disease is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Parkinson's Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- completed